Supernus Pharmaceuticals Profit Margin 2011-2024 | SUPN
Current and historical gross margin, operating margin and net profit margin for Supernus Pharmaceuticals (SUPN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Supernus Pharmaceuticals net profit margin as of September 30, 2024 is 9.16%.
| Supernus Pharmaceuticals Annual Profit Margins |
| Supernus Pharmaceuticals Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.962B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
